Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid C Rulifson

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 18, 2002
Inability to induce tolerance through direct antigen presentationIngrid C Rulifson, Gregory L Szot, Ed Palmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2002
Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cellsYuichi Hori, Ingrid C Rulifson, Bernette C Tsai, et al.
Diabetes|December 18, 2007
Regulated beta-cell regeneration in the adult mouse pancreasDavid A Cano, Ingrid C Rulifson, Patrick W Heiser, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2024
The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamicsDavid J Sherman, Lei Liu, Jennifer L Mamrosh, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamicsDavid J Sherman, Lei Liu, Jennifer L Mamrosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2007
Wnt signaling regulates pancreatic beta cell proliferationIngrid C Rulifson, Satyajit K Karnik, Patrick W Heiser, et al.
Cell Reports|October 5, 2025
PNPLA3-I148M is a neomorph that interferes with two primary hepatic triglyceride clearance pathwaysDavid J Sherman, Lei Liu, Edward L LaGory, et al.
Nucleic Acid Therapeutics|September 3, 2025
Use of a Transgenic Human PNPLA3<sup>I148M</sup> Knock-in Mouse for Translational Safety Evaluations of siRNA TherapeuticsBen Brooks, Artem Shkumatov, Jackson Kalanzi, et al.
Ebiomedicine|July 8, 2015
Soluble CLEC2 Extracellular Domain Improves Glucose and Lipid Homeostasis by Regulating Liver Kupffer Cell PolarizationXinle Wu, Jun Zhang, Hongfei Ge, et al.
The Journal of Biological Chemistry|December 25, 2016
In Vitro and in Vivo Analyses Reveal Profound Effects of Fibroblast Growth Factor 16 as a Metabolic RegulatorIngrid C Rulifson, Patrick Collins, Li Miao, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 18, 2002
Inability to induce tolerance through direct antigen presentationIngrid C Rulifson, Gregory L Szot, Ed Palmer, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 21, 2002
Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cellsYuichi Hori, Ingrid C Rulifson, Bernette C Tsai, et al.
Diabetes|December 18, 2007
Regulated beta-cell regeneration in the adult mouse pancreasDavid A Cano, Ingrid C Rulifson, Patrick W Heiser, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2024
The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamicsDavid J Sherman, Lei Liu, Jennifer L Mamrosh, et al.
Biorxiv : the Preprint Server for Biology|October 24, 2023
The fatty liver disease-causing protein PNPLA3-I148M alters lipid droplet-Golgi dynamicsDavid J Sherman, Lei Liu, Jennifer L Mamrosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 4, 2007
Wnt signaling regulates pancreatic beta cell proliferationIngrid C Rulifson, Satyajit K Karnik, Patrick W Heiser, et al.
Cell Reports|October 5, 2025
PNPLA3-I148M is a neomorph that interferes with two primary hepatic triglyceride clearance pathwaysDavid J Sherman, Lei Liu, Edward L LaGory, et al.
Nucleic Acid Therapeutics|September 3, 2025
Use of a Transgenic Human PNPLA3<sup>I148M</sup> Knock-in Mouse for Translational Safety Evaluations of siRNA TherapeuticsBen Brooks, Artem Shkumatov, Jackson Kalanzi, et al.
Ebiomedicine|July 8, 2015
Soluble CLEC2 Extracellular Domain Improves Glucose and Lipid Homeostasis by Regulating Liver Kupffer Cell PolarizationXinle Wu, Jun Zhang, Hongfei Ge, et al.
The Journal of Biological Chemistry|December 25, 2016
In Vitro and in Vivo Analyses Reveal Profound Effects of Fibroblast Growth Factor 16 as a Metabolic RegulatorIngrid C Rulifson, Patrick Collins, Li Miao, et al.
Pageof 2